We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

BRPT:IDXPT Barito Pacific Tbk Analysis

Data as of 2026-09-05 - not real-time

IDR 1,790.00

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

The moving-average structure behind PT Barito Pacific Tbk is neutral at IDR 1,790.00, with no clear ordering between short and long averages. With RSI at 47.5 the momentum picture is neutral, alongside a bearish MACD signal. Recent trading has carved out support near IDR 1,710.00 and resistance around IDR 1,965.00.
On valuation the read is overvalued — an earnings multiple of 67.6, absent a reliable peer benchmark. Revenue is growing at 26.9% on a 1.4% profit margin. The 0.09% dividend yield looks covered by current payout levels.
On a 1-10 scale the risk profile lands at 7 — elevated. With 30-day volatility of 42.5%, a beta of 0.58 and a maximum drawdown of 70.8%, position sizing matters more than entry timing here. The wider market backdrop reads extreme greed at 95 on the fear-greed composite.
Short, medium and long-term reads agree on sell, with conviction of 6/10.

Top Market Events

PT Barito Pacific Tbk has been in focus after recent operational and financing updates in its petrocPT Barito Pacific Tbk has recently updated shareholders on its 2026 annual general meeting decisionsad-hoc-news2monBarito outlines long-term strategy as PT Barito Pacific Tbk strengthens its portfolioOver recent years,...

Market Outlook

Short Term

< 1 year
Cautious
Model confidence: 6/10

Key Factors

  • Trading below the 200-day average of 2217.28
  • MACD momentum is negative
  • 30-day volatility of 42.5%

Medium Term

1–3 years
Cautious
Model confidence: 6/10

Key Factors

  • Trading below the 200-day average of 2217.28
  • 30-day volatility of 42.5%
  • MACD momentum is negative

Long Term

> 3 years
Cautious
Model confidence: 6/10

Key Factors

  • Revenue growth of +26.9%
  • Negative free cash flow
  • P/E ratio of 67.6

Key Metrics & Analysis

Financial Health

Revenue Growth26.90%
Profit Margin1.39%
P/E Ratio67.6
ROE6.46%
ROA2.21%
Debt/Equity133.06
P/B Ratio68846.2
Op. Cash FlowIDR290.5M
Free Cash FlowIDR-339438368

Technical Analysis

TrendNeutral
RSI47.5
SupportIDR 1,710.00
ResistanceIDR 1,965.00
MA 20IDR 1,846.50
MA 50IDR 1,742.20
MA 200IDR 2,217.28
MACDBearish
VolumeDecreasing
Fear & Greed Index95.48

Valuation

Fair ValueIDR 0.02
Target PriceIDR 1,763.70
Upside/Downside-1.47%
GradeOvervalued
TypeGrowth
Dividend Yield0.09%

Risk Assessment

Beta0.58
Volatility42.47%
Sector RiskMedium
Reg. RiskMedium
Geo RiskHigh
Currency RiskHigh
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.